Effect of hexamethylmelamine (NSC-13875) on small cell carcinoma of the lung (phase II study).
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy* / Q000532:radiotherapy; D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000627:therapeutic use; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007958:Leukocyte Count; D007970:Leukopenia / Q000139:chemically induced; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D012509:Sarcoma / Q000188:drug therapy*
D000970:Antineoplastic Agents; D004317:Doxorubicin